IS ACCELERATED CONTACT LENS-ASSISTED CROSS-LINKING (ACACXL) SAFE AND EFFECTIVE IN PATIENTS WITH CORNEA THICKNESS LESS THAN 400 MICRONS OR SHOULD ALTERNATIVE METHODS BE CONTINUED TO BE EXPLORED?